Wed, Oct 1, 2014, 9:04 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Elan Corporation, plc Message Board

  • dasbof dasbof Jun 2, 2005 12:44 PM Flag

    Story keeps getting WEAKER - READ

    Now they word it:

    <<There is a case with possible symptoms", said FDA spokeswoman Lenore Gelb, adding, "The case is being reviewed.">>

    Now it is "possible symtoms".

    Can you believe it???

    The papers got it wrong.

    Strong Buy.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Great but please provide link to article.

      • 1 Reply to dasbof
      • Thanks for the post.

        BIOGEN made a clarification that the Boston Globe said "Four patients are dead", and they refuted BG and said "Patient is Alive". I'm seeing a lawsuit here for misinformation.

        --------------------------------

        The U.S. Food and Drug Administration confirmed it was evaluating a possible fourth case of the rare brain infection PML in a patient who had taken Tysabri.

        "There is a case with possible symptoms", said FDA spokeswoman Lenore Gelb, adding, "The case is being reviewed."

        The Boston Globe reported earlier that Biogen, with which Elan developed the treatment, had told the FDA a fourth patient may have contracted progressive multifocal leukoencepalopathy (PML).

        "The patient referenced in that story is alive," said Biogen spokeswoman Amy Brockelman.

        She would not confirm whether the fourth patient was suspected to have PML but said, "We are reviewing any and all suspected cases. It's an extensive evaluation. We hope to have findings by the end of the summer."

        Brockelman noted that the Boston Globe headline mentioned four patient deaths tied to Tysabri. She said two patients are confirmed to have died from PML. A third patient with a confirmed case of PML remains alive.

        PML is a rare disease in which a virus attacks the protective sheath over cells in the central nervous system.

 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Vivint Solar, Inc.
NYSEWed, Oct 1, 2014 4:00 PM EDT
Angie's List, Inc.
NasdaqGSWed, Oct 1, 2014 4:00 PM EDT